ASO Author Reflections: Shifting Age Demographics in Prostate Cancer Surgery: Insights from 17 Years of German Data
Martin Baunacke, Johannes Huber, Lennard Haak, Christian Thomas, Christer Groeben
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —Technische Universität Dresden (1019)
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProstate Cancer Diagnosis and Treatment · Global Cancer Incidence and Screening · Frailty in Older Adults
Past
The study addresses the clinical question of how increasing patient age affects the utilization and outcomes of radical prostatectomy (RP) for prostate cancer. As life expectancy continues to rise in Western countries, more elderly men seek curative treatment.^1^ However, most previous studies were limited to single institutions and smaller cohorts, providing little insight into nationwide trends.^2,3^ The main scientific problem was the lack of population-based data examining whether older patients (particularly those aged ≥ 75 years) increasingly undergo RP and how age impacts perioperative outcomes such as mortality, transfusion rates, and hospital stay length.
Present
Using national hospital billing data from Germany (2006–2022; 444,102 cases), the study demonstrates a clear and continuous increase in the mean age of RP patients, with the proportion of men ≥ 75 years quadrupling from 3 to 12% over 17 years. Although older patients experienced higher in-hospital mortality (0.3% versus 0.1%), higher transfusion rates (5% versus 2%), and longer hospital stays (8.15 versus 7.57 days), these differences were statistically significant but clinically minor. Importantly, the study shows that RP, including robotic-assisted approaches, remains a feasible and safe option for well-selected elderly patients. It also highlights a shift in treatment decision-making—from rigid chronological age criteria to biological fitness and comorbidity assessment—reflecting increased flexibility in guideline adherence.^4^
Future
Future research should focus on functional outcomes (continence and erectile function) in elderly patients, as these aspects substantially affect quality of life but remain underexplored in national data.^5^ Studies should also assess whether the growing number of elderly RP patients impacts overall postoperative recovery and healthcare resource allocation. Furthermore, given the rising demand for surgical treatment among older men alongside a declining medical workforce, there is a need for strategic planning to ensure that these patients receive optimal care in high-volume, experienced centers. Future investigations integrating geriatric assessment tools and long-term oncological outcomes will be crucial for refining patient selection and treatment guidelines.